Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/27325| Title: | Alemtuzumab provides durable clinical efficacy in patients with active rrms in the absence of continuous treatment: 7-Year follow-up of CARE-MS I (TOPAZ Study) | Authors: | VAN WIJMEERSCH, Bart Vermersch, P. Boyko, A. de Seze, J. Hartung, H. -P. Havrdova, E. Kubala Inshasi, J. Said McCombe, P. Montalban, X. Pozzili, C. Melanson, M. Daizadeh, N. Rodriguez, C. Selmaj, K. |
Issue Date: | 2018 | Publisher: | WILEY | Source: | EUROPEAN JOURNAL OF NEUROLOGY, 25(S2), p. 24-25 | Notes: | [Van Wijmeersch, B.] Hasselt Univ, BIOMED, Rehabil & MS Ctr Overpelt, Hasselt, Belgium. [Vermersch, P.] Univ Lille, Lille, France. [Boyko, A.] Pirogov Russian Natl Res Univ, Moscow, Russia. [Boyko, A.] Usupov Hosp, Demyelinating Dis Ctr, Moscow, Russia. [de Seze, J.] Univ Strasbourg, Strasbourg, France. [Hartung, H. -P.] Heinrich Heine Univ, Dusseldorf, Germany. [Havrdova, E. Kubala] Charles Univ Prague, Fac Med 1, Prague, Czech Republic. [Inshasi, J. Said] Rashid Hosp, Dubai, U Arab Emirates. [Inshasi, J. Said] Dubai Med Coll, Dubai, U Arab Emirates. [McCombe, P.] Univ Queensland, Brisbane, Qld, Australia. [Montalban, X.] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada. [Montalban, X.] Hosp Univ Vall dHebron, Ctr Esclerosi Multiple Catalunya Cemcat, Barcelona, Spain. [Pozzili, C.] Sapienza Univ Rome, Rome, Italy. [Melanson, M.; Daizadeh, N.; Rodriguez, C.] Sanofi, Cambridge, MA USA. [Selmaj, K.] Med Univ Lodz, Lodz, Poland. | Document URI: | http://hdl.handle.net/1942/27325 | ISSN: | 1351-5101 | e-ISSN: | 1468-1331 | ISI #: | 000435272000041 | Category: | M | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.